ClinicalTrials.govpublic full text
BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients
ovarian cancer, vascular disrupting agents, bnc105p, partially platinum sensitive, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912592
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.